Mangalam Drugs and Organics share news, announcements and annual reports
NSE: MANGALAMBSE: 532637Pharmaceuticals & BiotechnologySmall Cap
Mangalam Drugs and Organics Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2005
Last close ₹28.61down ₹0.61 (2.09%)BSE ₹28.92
Share price at the NSE close on 30 Oct 2026. Previous close ₹29.22.
30 Oct: open ₹29.48, high ₹29.75, low ₹28.51
52-week range of traded prices to 30 Oct 2026
₹22.80Low, 29 Dec 2025₹68.40High, 30 Oct 2025
- Under NSE's long-term additional surveillance, stage I, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 5 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹45 Cr3,423rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.44
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −30.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −12.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 50,07391.9% delivered
Mangalam Drugs and Organics shareholding disclosures
42 filed, newest first.
Jun 2026
Apr 2026
Mar 2026
Nov 2025
Aug 2025
Jul 2025
Apr 2024
Jun 2023
Jun 2022
Apr 2022
Apr 2021
Feb 2021
Jun 2020
Apr 2019
Jun 2015
Apr 2015
Mar 2015
Dec 2014
Jan 2013
Dec 2012
Feb 2012
Dec 2011
Jan 2011
Dec 2010
Apr 2010
13 Apr · Disclosure
Disclosure of details of acquisition of Mangalam Drugs and Organic Limited (Target Company) and stock exchanges where the shares of the target Company are listed , in terms of regulations 7(1) and 7(1A). The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.13 Apr · Disclosure
Disclosure pursuant to regulations 7(3) and 13(6) SEBI (Substantial Acquisition of Shares and takeovers) Regualtions, 1997. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.8 Apr · Disclosure
Disclosure under Regulation 8A(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997. The details of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2009
11 Feb · Disclosure
Disclosure under Regulation 8A(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.